<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html id="nojs" xmlns="http://www.w3.org/1999/xhtml" xmlns:m="http://www.w3.org/1998/Math/MathML" xmlns:og="http://ogp.me/ns#" xml:lang="en-GB" lang="en-GB" xmlns:wb=“http://open.weibo.com/wb”>

<head>

   
  
      
  
                  
  
                  
  
            
  
            
            
    <title>Trials | Full text | Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial</title>
<link rel="shortcut icon" type="image/x-icon" href="/images/icon/10096/favicon.ico" />
<link rel="apple-touch-icon" sizes="72x72" href="/sites/10096/images/70.gif" />
<meta http-equiv="X-UA-Compatible" content="IE=7" />


                
    
		
		
		
		
<!-- <?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:cc="http://web.resource.org/cc/" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">
<cc:Work rdf:about="http://www.trialsjournal.com/content/16/1/5">
<cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
</cc:Work>
<cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
<cc:permits rdf:resource="http://web.resource.org/cc/Reproduction"/>
<cc:permits rdf:resource="http://web.resource.org/cc/Distribution"/>
<cc:requires rdf:resource="http://web.resource.org/cc/Notice"/>
<cc:requires rdf:resource="http://web.resource.org/cc/Attribution"/>
<cc:permits rdf:resource="http://web.resource.org/cc/DerivativeWorks"/>
</cc:License>
<item rdf:about="http://www.trialsjournal.com/content/16/1/5">
<title>Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial</title>
<dc:title>Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial</dc:title>
<dc:creator>Holm, Charlotte</dc:creator>
<dc:creator>Thomsen, Lars L</dc:creator>
<dc:creator>Norgaard, Astrid</dc:creator>
<dc:creator>Langhoff-Roos, Jens</dc:creator>
<dc:identifier>info:doi/10.1186/1745-6215-16-5</dc:identifier>
<dc:identifier>info:pmid/25588587</dc:identifier>
<dc:source>Trials 2015, 16:5</dc:source>
<dc:date>2015-01-14</dc:date>

<prism:publicationName>Trials</prism:publicationName>
<prism:publicationDate>2015-01-14</prism:publicationDate>
<prism:volume>16</prism:volume>
<prism:number>1</prism:number>
<prism:section>Study protocol</prism:section>
<prism:startingPage>5</prism:startingPage>
<prism:copyright>2015 Holm et al.; licensee BioMed Central.</prism:copyright>
</item>
</rdf:RDF>
 -->
 
 
<meta name="citation_journal_title" content="Trials" />
<meta name="citation_publisher" content="BioMed Central Ltd" />


<meta name="citation_author" content="Charlotte Holm" />
<meta name="citation_author_institution" content="Department of Obstetrics, Juliane Marie Centre, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK-2100 Kbh Ø Copenhagen, Denmark" />
<meta name="citation_author_institution" content="Pharmacosmos A/S, Roervangsvej 30, DK-4300 Holbaek, Denmark" />
<meta name="citation_author" content="Lars L Thomsen" />
<meta name="citation_author_institution" content="Pharmacosmos A/S, Roervangsvej 30, DK-4300 Holbaek, Denmark" />
<meta name="citation_author" content="Astrid Norgaard" />
<meta name="citation_author_institution" content="Section for Transfusion Medicine 2034, Capital Region Blood Bank, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK-2100 Kbh Ø Copenhagen, Denmark" />
<meta name="citation_author" content="Jens Langhoff-Roos" />
<meta name="citation_author_institution" content="Department of Obstetrics, Juliane Marie Centre, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK-2100 Kbh Ø Copenhagen, Denmark" />


<meta name="citation_issn" content="1745-6215" />
<meta name="citation_title" content="Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial" />
<meta name="citation_volume" content="16" />
<meta name="citation_issue" content="1" />
<meta name="citation_date" content="2015-01-14" />
<meta name="citation_firstpage" content="5" />
<meta name="citation_doi" content="10.1186/1745-6215-16-5" />
<meta name="citation_pdf_url" content="http://www.trialsjournal.com/content/pdf/1745-6215-16-5.pdf" />
<meta name="citation_pmid" content="25588587" />
<link rel="alternate" type="application/pdf" title="PDF" href="http://www.trialsjournal.com/content/pdf/1745-6215-16-5.pdf" />
<meta name="title" content="Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial" />
<meta name="description" content="Postpartum haemorrhage can lead to iron deficiency with and without anaemia, the clinical consequences of which include physical fatigue. Although oral iron is the standard treatment, it is often associated with gastrointestinal side effects and poor compliance. To date, no published randomised controlled studies have compared the clinical efficacy and safety of standard medical care with intravenous administration of iron supplementation after postpartum haemorrhage." />

<meta name="dc.title" content="Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial" />
<meta name="dc.creator" content="Holm, Charlotte" />
<meta name="dc.creator" content="Thomsen, Lars L" />
<meta name="dc.creator" content="Norgaard, Astrid" />
<meta name="dc.creator" content="Langhoff-Roos, Jens" />
<meta name="dc.description" content="Postpartum haemorrhage can lead to iron deficiency with and without anaemia, the clinical consequences of which include physical fatigue. Although oral iron is the standard treatment, it is often associated with gastrointestinal side effects and poor compliance. To date, no published randomised controlled studies have compared the clinical efficacy and safety of standard medical care with intravenous administration of iron supplementation after postpartum haemorrhage." />
<meta name="dc.source" content="Trials 2015 16:5" />
<meta name="dc.format" content="text/html" />
<meta name="dc.publisher" content="BioMed Central Ltd" />
<meta name="dc.date" content="2015-01-14" />
<meta name="dc.type" content="Study protocol" />
<meta name="dc.identifier" content="10.1186/1745-6215-16-5" />
<meta name="dc.identifier" content="info:pmid/25588587" />
<meta name="dc.language" content="en" />
<meta name="dc.copyright" content="2015 Holm et al.; licensee BioMed Central." />
<meta name="dc.rights" content="http://creativecommons.org/licenses/by/2.0/" />
<meta name="dc.rightsAgent" content="reprints@biomedcentral.com" />

<meta name="prism.issn" content="1745-6215" />
<meta name="prism.publicationName" content="Trials" />
<meta name="prism.publicationDate" content="2015-01-14" />
<meta name="prism.volume" content="16" />
<meta name="prism.number" content="1" />
<meta name="prism.section" content="Study protocol" />
<meta name="prism.startingPage" content="5" />
<meta name="prism.copyright" content="2015 Holm et al.; licensee BioMed Central." />
<meta name="prism.rightsAgent" content="reprints@biomedcentral.com" />


        <meta name="citation_abstract_html_url" content="http://www.trialsjournal.com/content/16/1/5/abstract" />
            <meta name="citation_fulltext_html_url" content="http://www.trialsjournal.com/content/16/1/5" />
            <link rel='alternate' type='text/xml' title='XML version' href='http://www.trialsjournal.com/content/download/xml/1745-6215-16-5.xml' />
            <link rel="image_src" href="http://www.trialsjournal.com/content/figures/1745-6215-16-5-toc.gif" />
    
     <link rel="section" href="http://trialsjournal.com/content/download/supplementary/1745-6215-16-5-s1.pdf" title="Additional file 1" />
    
    
                    
    

<script type="text/javascript">
// must run before css
document.documentElement.id = "js";
</script>



						
   
  
      
  
                  
  
                  
  
            
  
            
            



						
        <script type="text/javascript" src="http://www.bmcimg.com/javascript/plugins/jquery-1.8.2.min-0.js"></script>

	                <link rel="stylesheet" type="text/css" href="/css/main-0.css" media="screen, print"/>
    
                <link rel="stylesheet" type="text/css" href="/css/plugins-0.css" media="screen, print"/>
    



    

			                <link rel="stylesheet" type="text/css" href="http://www.bmcimg.com/css/articles-0.css" media="screen, print"/>
    	

    

    <link rel="stylesheet" type="text/css" href="/css/themes/10096.css" media="screen, print"/>


                <link rel="stylesheet" type="text/css" href="/css/media/print-0.css" media="print"/>
    



<!--[if IE]>
                    <link rel="stylesheet" type="text/css" href="/css/hacks/ie-0.css"/>
    <![endif]-->

<!--[if IE 7]>
                    <link rel="stylesheet" type="text/css" href="/css/hacks/ie7-0.css"/>
    <![endif]-->
			
<script type="text/javascript">
    //configuration
    OAS_url = '//oas.biomedcentral.com/RealMedia/ads/';

	// control of advert's position on page [AMC]
    
    	
	
    OAS_sitepage = "trialsjournal.com/article/10.1186/1745/6215/16/5";
    	
		OAS_listpos = 'Top,x96,Right3';
	
	
			
		OAS_query = '';
		
	

    OAS_target = '_top';
    //end of configuration
    OAS_version = 10;
    OAS_rn = '001234567890'; OAS_rns = '1234567890';
    OAS_rn = new String (Math.random()); OAS_rns = OAS_rn.substring (2, 11);
    function OAS_NORMAL(pos) {
		document.write('<a href="' + OAS_url + 'click_nx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '!' + pos + '?' + OAS_query + '" target="' + OAS_target + '">');
		document.write('<img src="' + OAS_url + 'adstream_nx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '!' + pos + '?' + OAS_query + '" border="0"/></a>');
    }
    
	function refererTerms(referer) {

	if(referer.match("q=") != null) {
		referer = referer.split("q=");
		referer = referer[1].split("&");
		referer = referer[0];
	} else {
		referer = referer;
	}

		if(referer.match("%20") != null && referer.match("%20").length >= 1) {
			referer =  referer.replace(/%20/gi,"+");
			return referer;
		} else { 
			return referer; 
		}
	}
 </script>


 <script type="text/javascript">
	// Set the version of JavaScript to 10 for a Browser 'Mozilla/3' on webTV 
    OAS_version = 11;
    if ((navigator.userAgent.indexOf('Mozilla/3') != -1) || (navigator.userAgent.indexOf('Mozilla/4.0 WebTV') != -1)) {
     OAS_version = 10; }
    if (OAS_version >= 11) {
    document.write('<scr' + 'ipt type="text/javascript" src="' + OAS_url + 'adstream_mjx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '?' + OAS_query + '"><\/script>'); }
</script>
	
<script type="text/javascript">
    document.write('');
	
    function OAS_AD(pos) {
        if (OAS_version >= 11)
         OAS_RICH(pos);
        else
         OAS_NORMAL(pos);
    }
 </script>
	





<script type="text/javascript">
    jsonLoaders = function(){
        var _loaders = [];
        return {
            register: function(config){
                config.prefix = config.prefix || '/webapi/1.0/blogs/';
                config.feedLength = config.feedLength || 3;

                _loaders.push(config);
            },
            list: function(){return _loaders}
        };
    }();

    function totext() {
	    document.write('<a href="javascript:returnToText();">Return to text</a>');
    }

    function retrieve_doi(){
        var metas = document.getElementsByTagName('meta');
        var i;
        for (i = 0; i < metas.length; i++)
            if (metas[i].getAttribute('name') == "citation_doi")
                break;
        var citation_doi = metas[i].getAttribute('content');
        return citation_doi;
    }

</script>





    <script src="http://tjs.sjs.sinajs.cn/open/api/js/wb.js" type="text/javascript" charset="utf-8"></script>
        <link title="Latest articles" rel="alternate" href="http://www.trialsjournal.com/latest/rss" type="application/rss+xml" exposeToHeader="true"/>
    <link title="Most viewed" rel="alternate" href="http://www.trialsjournal.com/mostviewed/rss/" type="application/rss+xml" exposeToHeader="true"/>
    <link title="Latest comments" rel="alternate" href="http://www.trialsjournal.com/latestcomments/rss" type="application/rss+xml" exposeToHeader="true"/>
    


	<script type="text/javascript">
	var _gaq = _gaq || [];
	_gaq.push(['_setAccount', 'UA-9663741-5']);
	_gaq.push(['_gat._anonymizeIp']);
	_gaq.push(['_setLocalRemoteServerMode']);
	
	/*for cross domain tracking*/
	//_gaq.push(['_setAllowLinker', true]);
    //_gaq.push(['_setDomainName', 'trialsjournal.com']); //this journal's domain
	/**/
	
		_gaq.push(['_trackPageview']); 

	(function() {
		var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
		ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
		var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);

		//var iframe = document.getElementById('casesdb-search-widget');
		//if(iframe !== null) {
		//	var pageTracker = _gat._getTrackerByName();
		//	iframe.src = pageTracker._getLinkerUrl('http://www.casesdatabase.com/');
		//}
	})();
	</script>

	
        </head>


<body class=" theme    ">


        



   
  
      
  
                  
  
                  
  
            
  
            
            

    

<div id="oas-campaign" style="display:none">trialsjournal.com/article/10.1186/1745/6215/16/5</div>
<div id="oas-positions" style="display:none">Bottom,Top</div>

<div id="branding" role="banner">
                			
		<dl class="google-ad wide ">
	<dt class="hide">
					<a class="banner-ad" href="http://www.biomedcentral.com/advertisers/digital_advertising"></a>
				
			</dt>
		<dd>

		<!-- OAS AD 'Top' begin -->
		<script type="text/javascript">
		OAS_AD('Top');

		</script>
		<!-- OAS AD 'Top' end -->
		</dd>

		</dl>

		<noscript>
			<dl class="google-ad wide noscript">  
    <dt class="hide"></dt>
    
    <dd>
        <a href="//oas.biomedcentral.com/RealMedia/ads/click_nx.ads/trialsjournal.com/article/10.1186/1745/6215/16/5/17375173339@Top?">
            <img src="//oas.biomedcentral.com/RealMedia/ads/adstream_nx.ads/trialsjournal.com/article/10.1186/1745/6215/16/5/11726553154@Top?" alt="advert"/>
        </a>
    </dd>
			</dl>
		</noscript>
			            <div class="sup-panel-outer">
        <div class="sup-panel-inner">

            <style>
  #nojs li.greeting, #nojs li#loginLink {display:none;}
</style>


<ul id="login" class="login">

    <noscript><li><a href="/log"><img class="greeting" src="/images/log.gif"/></a></li></noscript>
    
    <li id="welcome"><span id="username"></span></li>

    <li id="loginLink"><a href=""></a></li>
    
    
</ul>

<script>

function login() {

/* cookie getter/setter */
var allCookies = {
  getItem: function (sKey) {
    if (!sKey || !this.hasItem(sKey)) { return null; }
    return unescape(document.cookie.replace(new RegExp("(?:^|.*;\\s*)" + escape(sKey).replace(/[\-\.\+\*]/g, "\\$&") + "\\s*\\=\\s*((?:[^;](?!;))*[^;]?).*"), "$1"));
  },
  setItem: function (sKey, sValue, vEnd, sPath, sDomain, bSecure) {
    if (!sKey || /^(?:expires|max\-age|path|domain|secure)$/i.test(sKey)) { return; }
    var sExpires = "";
    if (vEnd) {
      switch (vEnd.constructor) {
        case Number:
          sExpires = vEnd === Infinity ? "; expires=Tue, 19 Jan 2038 03:14:07 GMT" : "; max-age=" + vEnd;
          break;
        case String:
          sExpires = "; expires=" + vEnd;
          break;
        case Date:
          sExpires = "; expires=" + vEnd.toGMTString();
          break;
      }
    }
    document.cookie = escape(sKey) + "=" + escape(sValue) + sExpires + (sDomain ? "; domain=" + sDomain : "") + (sPath ? "; path=" + sPath : "") + (bSecure ? "; secure" : "");
  },
  removeItem: function (sKey, sPath) {
    if (!sKey || !this.hasItem(sKey)) { return; }
    document.cookie = escape(sKey) + "=; expires=Thu, 01 Jan 1970 00:00:00 GMT" + (sPath ? "; path=" + sPath : "");
  },
  hasItem: function (sKey) {
    return (new RegExp("(?:^|;\\s*)" + escape(sKey).replace(/[\-\.\+\*]/g, "\\$&") + "\\s*\\=")).test(document.cookie);
  },
  keys: /* optional method: you can safely remove it! */ function () {
    var aKeys = document.cookie.replace(/((?:^|\s*;)[^\=]+)(?=;|$)|^\s*|\s*(?:\=[^;]*)?(?:\1|$)/g, "").split(/\s*(?:\=[^;]*)?;\s*/);
    for (var nIdx = 0; nIdx < aKeys.length; nIdx++) { aKeys[nIdx] = unescape(aKeys[nIdx]); }
    return aKeys;
  }
};

// converts cookie into js object
function parseCookie(cookie) {

    cookie = cookie.split("&");
    var obj = {};

    for(var i = 0; i < cookie.length; i++) {

        var c = cookie[i].split("=");

        c[0] = c[0].replace('"','');
        
        obj[c[0]] = c[1];

    }
    return obj;
}

    var cookie = allCookies.getItem("bmccookie");

    var obj = (cookie != null) ? parseCookie(cookie) : {};
    

        var welcome = "";

        if(obj.hasOwnProperty("fname")) {

            // insert user welcome
            welcome = obj.fname.replace(/\+/g, " ") + " " + obj['lname'].replace(/\+/g," ");

            if(jQuery("#welcome").length > 0) {
              jQuery("#welcome").prepend("<strong>Welcome</strong> ");
              jQuery("#username").prepend('<strong>' + welcome + '</strong><span class="divider"></span>');
            } 

            // update link url
            jQuery("#loginLink a").text("Log off");
            jQuery("#loginLink a").attr("href", window.location.protocol + "//" + window.location.host + "/logoff");

            window.bmcloggedon = true;


        } else if(obj.hasOwnProperty("institution_name")) {

            // insert institution name
            welcome = obj["institution_name"].replace(/\+/g," ");
            
            if(jQuery("#welcome").length > 0) { 
                jQuery("#welcome").prepend("<strong>Welcome</strong> ");
                jQuery("#username").prepend('<strong>' + welcome + '</strong><span class="divider"></span>');
            } 

            // update link url
            jQuery("#loginLink a").text("Log on");
            jQuery("#loginLink a").attr("href", window.location.protocol + "//" + window.location.host + "/logon");

            window.bmcloggedon = false;


        } else {
            jQuery("#welcome").innerHTML = "";
            jQuery("#loginLink a").text("Log on");
            jQuery("#loginLink a").attr("href", window.location.protocol + "//" + window.location.host + "/logon");

            window.bmcloggedon = false;

        }


        // if athens login cookie doesn't exist and the athens login link is visible then remove it.
        if(allCookies.hasItem("athens") != true && document.getElementById("loginAthensLink") != null) {
          jQuery("#loginAthensLink").hide();
        }

}

login();


</script>

            <ul class="nav-sup">

    
        <li id="BMC" class="current">
            <a href="http://www.biomedcentral.com/"><span class="img-title">&nbsp;</span>
            <span class="text-title">BioMed Central</span></a>
        </li>
		
        		<li><a href="http://www.biomedcentral.com/journals"><span>Journals</span></a></li>
		
								<li>
				<a href="http://www.biomedcentral.com/gateways"><span>Gateways</span></a>
			</li>
					    	
</ul>
        </div>
    </div>
    <div class="branding-inner">

        

    
<style>
.survey {
	margin: 10px 0;
}
.survey, .survey .survey-sentence {
	font-size: 13px;
}
.survey-button a, .survey-button a:active, .survey-button a:visited, .survey-button a:hover  {
    color: #FFFFFF;
    text-decoration: none;
}
.survey-button {
	background-color: #FFA500;
    border-radius: 5px;
    color: #FFFFFF;
    font-weight: bold;
    font-size: 13px;
    font-weight: bold;
    padding: 5px 13px;
    background: #ef8142; /* Old browsers */
	background: -moz-linear-gradient(top,  #ef8142 0%, #ef8142 50%, #a64510 100%, #a64510 100%); /* FF3.6+ */
	background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,#ef8142), color-stop(50%,#ef8142), color-stop(100%,#a64510), color-stop(100%,#a64510)); /* Chrome,Safari4+ */
	background: -webkit-linear-gradient(top,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* Chrome10+,Safari5.1+ */
	background: -o-linear-gradient(top,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* Opera 11.10+ */
	background: -ms-linear-gradient(top,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* IE10+ */
	background: linear-gradient(to bottom,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* W3C */
	filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#ef8142', endColorstr='#a64510',GradientType=0 ); /* IE6-9 */

}
</style>




          <div class="logo">
        <a href="/"><img alt="Trials" title="Trials Logo" src="/sites/10096/images/logo.gif" /></a>     
      </div>    
        
                    



            <div id="impact-factor" class="official">
    <img src="/images/branding/official.gif" alt="official impact factor" title="2.12"/>
    <span id="impact-factor-value">2.12</span>
</div>
    
                            

<div class="module search gray small  " role="search">
    <div class="module-inner padded">
        <form method="get" class="searchForm"
              action=" /quickSearchRedirectURL "
              onsubmit="window.location.href=this['url'].value + '?terms=' + encodeURIComponent(this['terms'].value); return false;">
            <fieldset class="search">
			                <span>
                    Search <select name="url">
                                <option value="http://www.trialsjournal.com/search/results" selected>Trials</option>
                                <option value="http://www.biomedcentral.com/search/results">BioMed Central</option>
                           </select> for
                </span>
                            <input id="searchTerms" name="terms" type="text" alt="Search terms" class="text " />
                 <button class="w37" value="Go" type="submit">Go</button>
            </fieldset>
        </form>
    </div>
	<a class="advanced-search" href="/search">Advanced search</a>
</div> 

                        <div id="mobile-nav-list" >

	<ul class="primary-nav" role="navigation">
		<li     ><a href="/"><span id="home-tab">Home</span></a></li>
														<li             class="current"
    ><a href="/content"><span id="articles-tab">Articles</span></a></li>
										
	

	
            <li     ><a href="/authors/instructions"><span id="authors-tab">Authors</span></a></li>
        <li     ><a href="/about/reviewers"><span id="reviewers-tab">Reviewers</span></a></li>
    		<li     ><a href="/about"><span id='about-tab'>About this journal</span></a></li>
	<li     ><a href="/my"><span id="my-tab">My Trials</span></a></li>
		
    		</ul>
</div>
            </div>
</div>

<hr class="hide" />
<div class="container">
	<div id="content"  class="overflow-visible"  role="main">
			    
	

<!--div class="branding-mobile">
		<h1 class="logo">
	    <a href="/">
		    <img alt="Trials" title="Trials Logo" src="/sites/10096/images/logo.gif" />
		</a>
		</h1>
	</div><br/-->



			
	



<div class="outline-wrapper block mobile-hidden" id="left-article-box">
<ul id="box-outline" class="box">
<ul id="outline" class="outline">
   <li>
      <a href="#">Top</a>
   </li>
   <li>
      <a href="#abs">Abstract</a>
   </li>
   <li>
      <a href="#sec1">Background</a>
   </li>
   <li>
      <a href="#sec2">Methods/Design</a>
   </li>
   <li>
      <a href="#sec3">Discussion</a>
   </li>
   <li>
      <a href="#sec4">Trial status</a>
   </li>
   <li>
      <a href="#sec5">Abbreviations</a>
   </li>
   <li>
      <a href="#sec6">Competing interests</a>
   </li>
   <li>
      <a href="#sec7">Authors’ contributions</a>
   </li>
   <li>
      <a href="#ack">Acknowledgements</a>
   </li>
   <li class="lowest">
      <a href="#refs">References</a>
   </li>
</ul>
</ul>

<dl id="box-outline1">
</dl>

				



</div>



<div class="mobile-hidden" id="right-panel">
 	
<div id="mobile-sidebar">
	<div id="mobile-sidebar-tab">
		<span>
			<a href="#" id="mobile-sidebar-tab-link"><img src="/images/sidebar-hidden.png"><img style="display:none;" src="/images/sidebar-shown.png"></a>
		</span>
	</div>	<div id="mobile-sidebar-list">

<div id="article-navigation-bar">
    <div class="issue-information block">
        <h5><a href="http://www.trialsjournal.com"><strong>Trials</strong></a></h5>
 		        <ul class="square normal">
            <li><a href="http://www.trialsjournal.com/content/16">Volume 16</a></li>
				
                    </ul>
    </div>

    <div class="article-information block" id="article-info">
        


<div id="viewing-options-links">
	<h5>Viewing options</h5>
	<ul class="square normal">
        
            <li>
                             <a onclick="_gaq.push(['_trackEvent', 'Abstract', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="/content/16/1/5/abstract">Abstract</a>
                        </li>
        				<li>
							<strong>Full text</strong>
					</li>
				
		<li class="pdfFileSize">
			<a onclick="_gaq.push(['_trackEvent', 'PDF download', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="/content/pdf/1745-6215-16-5.pdf">PDF</a>
			<span>(763KB)</span>
		</li>

        
				<li>
						<a onclick="_gaq.push(['_trackEvent', 'additional files', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="/content/16/1/5/additional">Additional files</a>
					</li>
			</ul>

        
</div>
		
<div id="associated-material-links">
    <h5>Associated material</h5>
    <ul class="square normal">
                        <li>
            <a onclick="_gaq.push(['_trackEvent', 'Pubmed record', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="/pubmed/25588587">PubMed record</a>
        </li>
                            <li><a onclick="_gaq.push(['_trackEvent', 'Article metrics', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="/content/16/1/5/about">Article metrics</a></li>
                <li>
                        <a onclick="_gaq.push(['_trackEvent', 'Readers comments', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="/content/16/1/5/comments">Readers' comments </a>
                    </li>
        <li>
                            <a onclick="_gaq.push(['_trackEvent', 'Pre-publication history', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="/content/16/1/5/prepub">Pre-publication history</a>                    </li>
    </ul>
</div>
		




<div id="related-literature-links">
    <h5>Related literature</h5>
    <ul class="normal">
                    <li><a onclick="_gaq.push(['_trackEvent', 'Citied by', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="http://www.trialsjournal.com/content/16/1/5/about#citations">Cited by</a></li>
                <li id="google-blog-search"><a onclick="_gaq.push(['_trackEvent', 'Google blog search', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="http://www.google.com/search?tbm=blg&hl=en&amp;source=hp&amp;biw=1280&amp;bih=899&amp;q=%22Intravenous+iron+isomaltoside+1000+administered+by+high+single-dose+infusions+or+standard+medical+care+for+the+treatment+of+fatigue+in+women+after+postpartum+haemorrhage%3A+study+protocol+for+a+randomised+controlled+trial%22&amp;btnG=Search">Google blog search</a></li>
        <h6>Other articles by authors</h6>
        <li>
            <a class="collapser"><i>&nbsp;</i>on Google Scholar</a>
<ul id="authg" class="hidebeforeload">                         <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22C+Holm%22">Holm C</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22LL+Thomsen%22">Thomsen LL</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22A+Norgaard%22">Norgaard A</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22J+Langhoff-Roos%22">Langhoff-Roos J</a>
            </li>
            </ul>          </li>
                <li>
            		<a class="collapser"><i>&nbsp;</i>on PubMed</a>
	<ul id="authpm" class="hidebeforeload"> 									<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Holm_C%20[Author]">Holm C</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Thomsen_LL%20[Author]">Thomsen LL</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Norgaard_A%20[Author]">Norgaard A</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Langhoff-Roos_J%20[Author]">Langhoff-Roos J</a>
				</li>
						</ul > 	        </li>
    </ul>     <h6>Related articles/pages</h6>
    <ul class="square normal">
        <li><a onclick="_gaq.push(['_trackEvent', 'on google', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="http://www.google.co.uk/search?hl=en&amp;q=related:http://www.trialsjournal.com/content/16/1/5">on Google</a></li>
        <li><a onclick="_gaq.push(['_trackEvent', 'on google scholar', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="http://scholar.google.com/scholar?q=related:http://www.trialsjournal.com/content/16/1/5">on Google Scholar</a></li>
                    <li><a onclick="_gaq.push(['_trackEvent', 'on Pubmed', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="/pubmed/related/25588587">on PubMed</a></li>
            </ul>

</div>		
        
    
    
        

    	






<h5>Tools</h5>
	<ul class="square normal">
									<li>
						<a onclick="_gaq.push(['_trackEvent', 'download references', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="/content/16/1/5/citation">Download references</a>
					</li>
				<li><a onclick="_gaq.push(['_trackEvent', 'download xml', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="/content/download/xml/1745-6215-16-5.xml">Download XML</a></li>
				<li>
						<a onclick="_gaq.push(['_trackEvent', 'email2friend', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="/content/16/1/5/email">Email to a friend</a>
					</li>
		<li><a onclick="_gaq.push(['_trackEvent', 'order reprints', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=738&doi=10.1186/1745-6215-16-5&volume=16&issue=1&title=Intravenous+iron+isomaltoside+1000+administered+by+high+single-dose+infusions+or+standard+medical+care+for+the+treatment+of+fatigue+in+women+after+postpartum+haemorrhage%3A+study+protocol+for+a+randomised+controlled+trial&author_name=Charlotte Holm&start_page=1&end_page=8">Order reprints</a></li>
		<li>
						<a onclick="_gaq.push(['_trackEvent', 'post a comment', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="/content/16/1/5/postcomment">Post a comment</a>
					</li>			
		<ul id="download-to-links">
			<a class="downloadto_title btn" href="#"><span class="icon">&nbsp;</span>Download to ...</a>
			
			<ul id="downloadto" class="iconlist hidebeforeload" style="display: none;">
				<li>
					<a href="http://redirect.papersapp.com/redirect?url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F5" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Papers', 'Article Sidebar', '/content/16/1/5', 1, true]);"><span class="share-icons papers"></span>Papers</a>
				</li>
				<li>
					<a href="http://www.mendeley.com/import/?url=http://www.trialsjournal.com/content/16/1/5" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Mandeley', 'Article Sidebar', '/content/16/1/5', 1, true]);"><span class="share-icons mendeley"></span>Mendeley</a>
				</li>
			</ul>
		</ul>
		
		<ul id="mobile-downloadto" class="iconlist">
		
		<h6>Download to ...</h6>
			<li>
				<a href="http://redirect.papersapp.com/redirect?url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F5" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Papers', 'Article Sidebar', '/content/16/1/5', 1, true]);"><span class="share-icons papers"></span>Papers</a>
			</li>
			
			<li>
				<a href="http://www.mendeley.com/import/?url=http://www.trialsjournal.com/content/16/1/5" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Mandeley', 'Article Sidebar', '/content/16/1/5', 1, true]);"><span class="share-icons mendeley"></span>Mendeley</a>
			</li>
		</ul>

		
	</ul>
		




<h5>Share this article</h5>
<ul id="social-networking-links">
	<li>
	<div class="fb-like" onclick="_gaq.push(['_trackEvent', 'Facebook Recommend', 'Article Sidebar', '/content/16/1/5', 1, true]);" data-href="http://www.trialsjournal.com/content/16/1/5" data-send="false" data-layout="button_count" data-width="100" data-show-faces="false" data-action="recommend"></div>
	</li>
	<li>
		<a onclick="_gaq.push(['_trackEvent', 'Share Twitter Recommend', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="http://twitter.com/share" data-url="http://www.trialsjournal.com/content/16/1/5" data-counturl="http://www.trialsjournal.com/content/16/1/5" data-hashtags="trials
" data-text="Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial" class="twitter-share-button">Tweet</a>
	</li>
	<li>
			<g:plusone size="medium" width="100"></g:plusone>
	</li>

        <li>
        <wb:share-button onclick="_gaq.push(['_trackEvent', 'Recommend Google plus', 'Article Sidebar', '/content/16/1/5', 1, true]);" addition="number" type="button" ralateUid="2216240737" title="Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial http://www.trialsjournal.com/content/16/1/5"></wb:share-button>
    </li>
    
		<a class="sharethis_title btn" href="#"><span class="icon">&nbsp;</span>More options...</a>
	<ul class="iconlist hidebeforeload" id="sharethis">
			<li>
				<a target="_blank" onclick="_gaq.push(['_trackEvent', 'citeu Like', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="http://www.citeulike.org/posturl?url=http://www.trialsjournal.com/content/16/1/5"><span class="share-icons citeulike"></span>Citeulike</a>
			</li>
				<li>
			<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share Linkedin', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="http://www.linkedin.com/shareArticle?mini=true&url=%26%2335%3Btrials%0D%0AIntravenous%20iron%20isomaltoside%201000%20administered%20by%20high%20single-dose%20infusions%20or%20standard%20medical%20care%20for%20the%20treatment%20of%20fatigue%20in%20women%20after%20postpartum%20haemorrhage%3A%20study%20protocol%20for%20a%20randomised%20controlled%20trial%20http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F5&title=Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial"><span class="share-icons linkedin"></span>LinkedIn</a>
	</li>
			<li>
				<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share delicious', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="http://del.icio.us/post?url=http://www.trialsjournal.com/content/16/1/5&title=Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial"><span class="share-icons delicious"></span>Del.icio.us</a>
	</li>
			<li>
				<a onclick="_gaq.push(['_trackEvent', 'Share via email', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="/content/16/1/5/email"><span class="share-icons email"></span>Email</a>
	</li>
			<li>
				<a onclick="target="_blank" onclick="_gaq.push(['_trackEvent', 'Share facebook', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="http://www.facebook.com/sharer.php?u=http://www.trialsjournal.com/content/16/1/5"><span class="share-icons facebook"></span>Facebook</a>
	</li>
	<li class="gp">
			<div class="googlehider mobile-hide"> 
				<div class="g-plusone" data-annotation="none"></div>
			</div>
				<span class="share-icons googleplus mobile-hide"></span>
				<div class="googlehider2 mobile-hide"> 
				<div class="g-plusone mobile-hide" data-annotation="none"></div>
			</div>
				<span class="share-icons googleplus"></span>
				<span class="gp-link"><a  onclick="_gaq.push(['_trackEvent', 'Share google plus', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="#">Google+</a></span>
	</li>
			<li>
				<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share Mandeley', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="http://www.mendeley.com/import/?url=http://www.trialsjournal.com/content/16/1/5"><span class="share-icons mendeley"></span>Mendeley</a>
			</li>
			<li>
			<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share twitter icon', 'Article Sidebar', '/content/16/1/5', 1, true]);" href="http://twitter.com/?status=Intravenous%20iron%20isomaltoside%201000%20administered%20by%20high%20single-dose%20infusions%20or%20standard%20medical%20care%20for%20the%20treatment%20of%20fatigue%20in%20women%20after%20postpartum%20haemorrhage%3A%20study%20protocol%20for%20a%20randomised%20controlled%20trial%20http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F5+%23trials
"><span class="share-icons twitter"></span>Twitter</a>
			</li>

			<li><a href="http://www.reddit.com/submit" onclick="window.location = 'http://www.reddit.com/submit?url=http://www.trialsjournal.com/content/16/1/5'; return false"> <span class="share-icons reddit"></span>Reddit</a>
    </li>






		</ul>
</ul>

    </div>

    
  
        
                
        


















                                                                                
	

	    
   
  
      
  
                  
  
                  
  
            
  
            
            

<div id="signup-to-etoc" class="button-collection-margins block mobile-border-bottom">	
					<h3>Email updates</h3>
			<p id="receive_issue_alerts_journal_updates_text">Keep up to date with the latest news and content from Trials and BioMed Central.</p>
			
				
<form  id="articleSignupForUpdates"  method="post" action="/signuptoupdates.html">
	<div id="message-box"></div>
    <fieldset class="block-form">
        <input type="text" name="emailAddress" onblur="javascript: if (this.value == '') { this.value = 'email address'; }" onfocus="javascript: if (this.value == 'email address') { this.value = ''; }" value="email address"  class="text " id="email" />
        <input value="" type="hidden" name="returnUrl" id="returnUrl" />
        <input value="xniche-trials" type="hidden" name="listName" id="listName" />
        <input value="Trials" type="hidden" name="journalName" id="journalName" />
        <button onclick="_gaq.push('_trackEvent', 'Signup', 'Signup for Email updates', "Trials");" class="w74 right" type="submit" onmouseover="this.className='w74 hover right'" onmouseout="this.className='w74 right'" value="Sign up">Sign up</button>
    </fieldset>
</form>	
</div>

	


			<div id="advert-offset">
    					
		<dl class="google-ad  ">
	<dt class="hide">
				
					<a class="skyscraper-ad" href="http://www.biomedcentral.com/advertisers/digital_advertising">Advertisement</a>
			</dt>
		<dd>

		<!-- OAS AD 'Right3' begin -->
		<script type="text/javascript">
		OAS_AD('Right3');

		</script>
		<!-- OAS AD 'Right3' end -->
		</dd>

		</dl>

		<noscript>
			<dl class="google-ad  noscript">  
    <dt class="hide"><a href="http://www.biomedcentral.com/advertisers/digital_advertising">Advertisement</dt>
    
    <dd>
        <a href="//oas.biomedcentral.com/RealMedia/ads/click_nx.ads/trialsjournal.com/article/10.1186/1745/6215/16/5/11272999726@Right3?">
            <img src="//oas.biomedcentral.com/RealMedia/ads/adstream_nx.ads/trialsjournal.com/article/10.1186/1745/6215/16/5/11204609648@Right3?" alt="advert"/>
        </a>
    </dd>
			</dl>
		</noscript>
					</div>
	

	
</div>
		<div class="mobile-sidebar-gradient top"></div>
		<div class="mobile-sidebar-gradient bottom"></div>
	</div>

</div>








 </div>
<div class="rounded custom white article full-text">
<div class="wrap-inner content">
    <div class="padded-inner">            


    
   
  
      
  
                  
  
                  
  
            
  
            
            

<div id="topmatter">
	


	   






 
  



				<a href="/about/access"><img alt="Open Access" src="/images/articles/openaccess-large.png" class="access mr15"/></a>
			<a href="http://www.biomedcentral.com/about/mostviewed/"><img alt="Highly Accessed" src="/images/articles/highlyaccessed-large.png" class="access mr15"/></a>
				<span class="articletype">Study protocol</span>

<h1>Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial</h1>
        
			<div class="multipleins">
		
	<p class="authors">
        																																																																																																																																							         <strong>Charlotte Holm</strong><sup><a href="/content/16/1/5/#ins1">1</a></sup><sup><a href="/content/16/1/5/#ins2">2</a></sup><sup>&#42;</sup>, <strong>Lars Lykke Thomsen</strong><sup><a href="/content/16/1/5/#ins2">2</a></sup>, <strong>Astrid Norgaard</strong><sup><a href="/content/16/1/5/#ins3">3</a></sup> and <strong>Jens Langhoff-Roos</strong><sup><a href="/content/16/1/5/#ins1">1</a></sup>	</p>
	
				<div id="affiliations">
		<div class="module gray  inner">
<div class="module-inner padded-inner">
		<ul>
			<li>                        
                                                                		<p class="authors" >
							<span>*</span>
									 Corresponding author:										            Charlotte  Holm <a href='mailto:charlotteholm@dadlnet.dk'>charlotteholm@dadlnet.dk</a>    					</p>
      
</li>
			
                                                                                                                                		</ul>

		
		 <p class="options"><a class="affiliations-toggle" href="#"><i class="arrow"></i>Author Affiliations</a></p>            <section> 
						<div class="collapsible-content">
							
				<div id="ins_container" style="display: block;">
										    						    <p >
						        <sup id="ins1">1</sup>                                Department of Obstetrics, Juliane Marie Centre, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK-2100 Kbh Ø Copenhagen, Denmark
                            </p>
																    						    <p >
						        <sup id="ins2">2</sup>                                Pharmacosmos A/S, Roervangsvej 30, DK-4300 Holbaek, Denmark
                            </p>
																    						    <p >
						        <sup id="ins3">3</sup>                                Section for Transfusion Medicine 2034, Capital Region Blood Bank, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, DK-2100 Kbh Ø Copenhagen, Denmark
                            </p>
																
				</div>
										<p id="authoremails">            For all author emails, please <a href="/logon">log on</a>.
    </p>
						</div>
			</section>
				</div>
</div>
		</div>
	  </div>

            <section class="cit">
                        <div class="collapsible-content">
        <p><em>Trials</em> 2015, <strong>16</strong>:5&nbsp;
			<span class="pseudotab">doi:10.1186/1745-6215-16-5</span></p>
	    				    
    
        
                
		<p>The electronic version of this article is the complete one and can be found online at: <a href="http://www.trialsjournal.com/content/16/1/5">http://www.trialsjournal.com/content/16/1/5</a></p>
		<br/>
                    <table cellspacing="0" cellpadding="0">
        <tbody>
        <tr><td>Received:</td><td>8 July 2014</td></tr>                <tr><td>Accepted:</td><td>10 December 2014</td></tr>        <tr><td>Published:</td><td>14 January 2015</td></tr>        </tbody>
        </table>
    		<!--<br/>-->
		<div  style="line-height:140%">
        <p>
            &copy; 2015 Holm et al.; licensee BioMed Central. <br />
        </p>
					<p>
				This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href='http://creativecommons.org/licenses/by/4.0'>http://creativecommons.org/licenses/by/4.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
			</p>
		    	</div>
	</section>

</div>
<div id="article-body">
    <section><a name="abs"></a><h3>Abstract</h3>
   <div class="collapsible-content">
      <h4>Background</h4>
      <p style="line-height:160%">Postpartum haemorrhage can lead to iron deficiency with and without anaemia, the clinical
         consequences of which include physical fatigue. Although oral iron is the standard
         treatment, it is often associated with gastrointestinal side effects and poor compliance.
         To date, no published randomised controlled studies have compared the clinical efficacy
         and safety of standard medical care with intravenous administration of iron supplementation
         after postpartum haemorrhage.
      </p>
      <p style="line-height:160%">The primary objective of this study is to compare the efficacy of an intravenous high
         single-dose of iron isomaltoside 1000 with standard medical care on physical fatigue
         in women with postpartum haemorrhage.
      </p>
      <h4>Methods/Design</h4>
      <p style="line-height:160%">In a single centre, open-labelled, randomised trial, women with postpartum haemorrhage
         exceeding 700&nbsp;mL will be allocated to either a single dose of 1,200&nbsp;mg of iron isomaltoside
         1000 or standard medical care. Healthy parturients with a singleton pregnancy will
         be included within 48&nbsp;hours after delivery.
      </p>
      <p style="line-height:160%">Participants will complete structured questionnaires that focus on several dimensions
         of fatigue and mental health (Multidimensional Fatigue Inventory, Edinburgh Postnatal
         Depression Scale and the Postpartum Questionnaire), at inclusion and at follow-up
         visits after three days, one week, three weeks, eight weeks, and 12&nbsp;weeks postpartum.
         The primary endpoint is the aggregated change in physical fatigue score within 12&nbsp;weeks
         postpartum, as measured by a subscale of the Multidimensional Fatigue Inventory. The
         primary objective will be considered to have been met if an intravenous high single
         dose of iron isomaltoside 1000 is shown to be superior to standard medical care in
         women after postpartum haemorrhage regarding physical fatigue.
      </p>
      <p style="line-height:160%">For claiming superiority, we set the minimal clinically relevant difference between
         the mean scores at 1.8, and the assumed standard deviation at 4.2. Hence, 87 participants
         per treatment group are needed in order to demonstrate superiority; to provide an
         extra margin for missing data and dropouts, 200 women will be included.
      </p>
      <h4>Discussion</h4>
      <p style="line-height:160%">The study will provide evidence on relevant clinical outcomes beyond biochemical parameters
         for intravenous iron isomaltoside 1000 compared to standard medical care in women
         after postpartum haemorrhage.
      </p>
      <h4>Trial registration</h4>
      <p style="line-height:160%">This trial is registered with Clinicaltrials.gov (identifier: <a href="https://www.clinicaltrials.gov/ct2/show/NCT01895218?term=NCT01895218&amp;rank=1">NCT01895218</a>) on 26 June 2013.
      </p>
   </div>
</section><span id="keywords">
   <h5 class="inline">Keywords: </h5>Postpartum haemorrhage; Iron deficiency; Intravenous iron; Postpartum fatigue</span><section><a name="sec1"></a><h3>Background</h3>
   <div class="collapsible-content">
      <h4>Postpartum iron deficiency and anaemia</h4>
      <p style="line-height:160%">Blood loss of up to 500&nbsp;mL at delivery is considered to be a normal physiological
         mechanism that brings a woman’s haemoglobin value back to the pre-pregnancy level
         <a name="d70682e176"></a><a name="d70682e178"></a>[<a onclick="LoadInParent('#B1'); return false;" href="#B1">1</a></a>,<a onclick="LoadInParent('#B2'); return false;" href="#B2">2</a>]. Severe postpartum haemorrhage (PPH) is defined as blood loss above 1,000&nbsp;mL within
         the first 24&nbsp;hours after delivery <a name="d70682e182"></a>[<a onclick="LoadInParent('#B3'); return false;" href="#B3">3</a>]. Full body iron stores can replete blood loss up to a maximum of 1,000&nbsp;mL <a name="d70682e186"></a>[<a onclick="LoadInParent('#B4'); return false;" href="#B4">4</a>], which means that many women with a blood loss between 500 and 1,000&nbsp;mL will develop
         iron deficiency with or without anaemia. Therefore, in the present study of iron supplementation,
         we considered ≥700&nbsp;mL blood loss to be the appropriate clinically significant criteria
         for inclusion.
      </p>
      <p style="line-height:160%">Postpartum iron deficiency anaemia may lead to several clinical consequences, the
         most prominent of which is maternal physical fatigue <a name="d70682e192"></a>[<a onclick="LoadInParent('#B5'); return false;" href="#B5">5</a>]. It is currently unknown whether treatment can help this fatigue or whether biochemical
         markers, such as haemoglobin (Hb), ferritin and other biomarkers, can measure the
         condition and predict clinical treatment effects.
      </p>
      <p style="line-height:160%">Breastfeeding is important for the health of the infant. Delayed onset of postpartum
         lactogenesis increases the risk of inadequate infant growth and early discontinuation
         of breastfeeding <a name="d70682e198"></a><a name="d70682e200"></a>[<a onclick="LoadInParent('#B6'); return false;" href="#B6">6</a></a>,<a onclick="LoadInParent('#B7'); return false;" href="#B7">7</a>]. A retrospective Canadian study found postpartum iron deficiency anaemia to be negatively
         associated with the duration of breastfeeding <a name="d70682e204"></a>[<a onclick="LoadInParent('#B8'); return false;" href="#B8">8</a>], but it is unknown whether postpartum iron deficiency anaemia is associated with
         delayed postpartum lactogenesis, or if the duration of breastfeeding can be improved
         with iron treatment after delivery.
      </p>
      <p style="line-height:160%">The clinical consequences of postpartum iron deficiency without anaemia are not known
         in detail. However, iron deficiency without anaemia in women of childbearing age is
         associated with fatigue, impaired physical work performance, deficient cognitive functions
         and mood disturbances <a name="d70682e210"></a>[<a onclick="LoadInParent('#B9'); return false;" href="#B9">9</a>]. Therefore, it is possible that postpartum iron deficiency without anaemia contributes
         significantly to physical fatigue in the puerperium, and that iron treatment is beneficial
         for these women and their infants.
      </p>
      <h4>Intravenous iron</h4>
      <p style="line-height:160%">The currently available intravenous iron preparations are generally considered equally
         efficacious but vary in terms of molecular size, kinetics, bioavailability and toxicology
         <a name="d70682e220"></a><a name="d70682e222"></a>[<a onclick="LoadInParent('#B10'); return false;" href="#B10">10</a></a>,<a onclick="LoadInParent('#B11'); return false;" href="#B11">11</a>]. The European Medicines Agency recently reviewed the safety of intravenous iron.
         It concluded that the benefits of intravenous iron are greater than their risks and
         was unable to establish a difference in the safety profiles of the products <a name="d70682e226"></a>[<a onclick="LoadInParent('#B12'); return false;" href="#B12">12</a>].
      </p>
      <p style="line-height:160%">Isomaltoside 1000, the carbohydrate component in iron isomaltoside 1000 (Monofer®),
         has a mean molecular weight of 1,000&nbsp;Da and consists predominantly of three to five
         glucose units. The carbohydrate isomaltoside is linear and unbranched with a low immunogenic
         potential. Iron isomaltoside 1000 has strongly bound iron within the iron isomaltoside
         formulation, which enables a controlled slow release of bioavailable iron to the iron-binding
         proteins with minimal risk of free iron toxicity <a name="d70682e232"></a>[<a onclick="LoadInParent('#B13'); return false;" href="#B13">13</a>].
      </p>
      <p style="line-height:160%">To date, iron isomaltoside 1000 has been approved in Europe for the treatment of iron
         deficiency anaemia. The indications are when oral iron preparations are ineffective
         or cannot be used, or where there is a clinical need to deliver iron rapidly. Several
         studies of iron isomaltoside 1000 treatment of iron deficiency anaemia have been published,
         including the use of bolus injections and high single-dose infusions, without detected
         unexpected safety issues <a name="d70682e238"></a><a name="d70682e240"></a><a name="d70682e242"></a><a name="d70682e244"></a>[<a onclick="LoadInParent('#B14'); return false;" href="#B14">14</a>-<a onclick="LoadInParent('#B17'); return false;" href="#B17">17</a>].
      </p>
      <p style="line-height:160%">Iron isomaltoside 1000 was chosen for this study as it is approved for high single
         dosing of up to 20&nbsp;mg/kg. The high single dose is preferable in the treatment of puerperal
         women, as they need fast correction of their iron deficit before leaving the hospital.
      </p>
      <h4>Previous studies and current guidelines</h4>
      <p style="line-height:160%">International guidelines are available for the treatment of iron deficiency anaemia
         in pregnancy and the postpartum period <a name="d70682e256"></a><a name="d70682e258"></a><a name="d70682e260"></a><a name="d70682e262"></a>[<a onclick="LoadInParent('#B18'); return false;" href="#B18">18</a>-<a onclick="LoadInParent('#B21'); return false;" href="#B21">21</a>]. These guidelines recommend oral iron supplementation in mild anaemia, intravenous
         iron in moderate anaemia and when oral iron supplementation is not tolerated, and
         allogeneic red blood cell (RBC) transfusion in severe and symptomatic cases. These
         guidelines do not deal with screening for or treatment of iron deficiency without
         anaemia.
      </p>
      <p style="line-height:160%">Denmark has no published national guideline on the screening or treatment of postpartum
         iron deficiency with or without anaemia. In clinical practice, doctors usually recommend
         oral iron supplementation to parturients with PPH, and RBC transfusion to those with
         severe symptoms of anaemia. Since puerperal women with a Hb level of ≤6.5&nbsp;g/dL (4.0&nbsp;mmol/L)
         often have severe symptoms of anaemia, we will not include these parturients in the
         study.
      </p>
      <p style="line-height:160%">No prospective randomised clinical studies have yet assessed the effect of intravenous
         iron supplementation in comparison to standard medical care in women after PPH with
         a clinical outcome as the primary endpoint. There have been 10 randomised controlled
         studies that have compared intravenous iron to oral iron supplementation in women
         with diagnosed postpartum iron deficiency anaemia <a name="d70682e270"></a><a name="d70682e272"></a><a name="d70682e274"></a><a name="d70682e276"></a><a name="d70682e278"></a><a name="d70682e280"></a><a name="d70682e282"></a><a name="d70682e284"></a><a name="d70682e286"></a><a name="d70682e288"></a>[<a onclick="LoadInParent('#B22'); return false;" href="#B22">22</a>-<a onclick="LoadInParent('#B31'); return false;" href="#B31">31</a>]. The inclusion criteria of these studies were Hb concentration up to 10&nbsp;days after
         delivery, and the primary study endpoints were Hb concentration, iron parameters and
         comparisons thereof. Generally, these studies have demonstrated improvement of Hb
         and iron parameters, favouring intravenous iron. With regard to safety, oral iron
         was associated with gastrointestinal side effects in up to 30% of the participants,
         with a compliance rate as low as 50%. These findings must be balanced against the
         very low risk of severe hypersensitivity reactions with intravenous iron <a name="d70682e292"></a>[<a onclick="LoadInParent('#B12'); return false;" href="#B12">12</a>].
      </p>
      <p style="line-height:160%">Hb concentration and other biochemical parameters are influenced by the haemodynamic
         changes, and are therefore considered unreliable for diagnosing iron deficiency anaemia
         in the first week(s) after giving birth <a name="d70682e298"></a>[<a onclick="LoadInParent('#B32'); return false;" href="#B32">32</a>]. However, it is crucial that these women can benefit from treatment in the clinically
         important first days after delivery. In the present study, we have chosen to include
         women based on their clinically estimated blood loss after delivery, and we hypothesise
         that women with clinically significant PPH will have an increased risk of developing
         iron deficiency with or without anaemia.
      </p>
      <p style="line-height:160%">We believe that iron treatment should be administered in order to improve clinical
         symptoms of iron deficiency with or without anaemia, not just to improve biochemical
         markers. This is in accordance with a systematic review, which concluded that there
         is a lack of high-quality studies with clinical outcomes <a name="d70682e304"></a>[<a onclick="LoadInParent('#B33'); return false;" href="#B33">33</a>]. Therefore, we have decided that the primary outcome in the present study will be
         a clinically significant improvement in the physical fatigue score between the treatment
         groups. We hypothesise that intravenous iron is superior to standard medical care.
      </p>
      <h4>Objective</h4>
      <p style="line-height:160%">The primary objective of this study is to compare the efficacy of intravenous high
         single doses of iron isomaltoside 1000 to standard medical care on physical fatigue
         in women with PPH.
      </p>
   </div>
</section>
<section><a name="sec2"></a><h3>Methods/Design</h3>
   <div class="collapsible-content">
      <h4>Study design</h4>
      <p style="line-height:160%">The study will be a randomised, comparative, open-label single-centre study with a
         1:1 allocation ratio. The trial is a company-sponsored interventional trial conducted
         according to International Conference on Harmonization-Good Clinical Practice (ICH-GCP)
         guidelines <a name="d70682e324"></a>[<a onclick="LoadInParent('#B34'); return false;" href="#B34">34</a>].
      </p>
      <h4>Inclusion criteria</h4>
      <p style="line-height:160%">Women, regardless of mode of delivery, will be eligible for inclusion in the study
         if they fulfil the following criteria: (1) they have signed the informed consent form,
         and (2) they have either (a) PPH ≥700 and ≤1,000&nbsp;mL or (b) PPH &gt;1,000&nbsp;mL and Hb &gt;6.5&nbsp;g/dL
         (4.0&nbsp;mmol/L) measured at &gt;12&nbsp;hours after delivery (Figure&nbsp;<a name="d70682e333"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/5/figure/F1','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/5/figure/F1">1</a>).
      </p><div class="figs">
      <div class="fig"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/5/figure/F1','F1',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/5/figure/F1"><img align="top" src="/content/figures/1745-6215-16-5-1.gif" alt="thumbnail" class="thumbnail"><strong>Figure 1.</strong></a> <strong>Trial flow.</strong> Women with postpartum haemorrhage ≥700 and ≤1,000&nbsp;mL or PPH &gt;1,000&nbsp;mL and haemoglobin
         &gt;6.5&nbsp;g/dL (4.0&nbsp;mmol/L) within 48&nbsp;hours of delivery will be screened for inclusion
         and exclusion and asked for consent to participate. Baseline questionnaires are completed
         and blood samples are taken. The participants are randomised to either intravenous
         iron isomaltoside 1000 or standard medical care. Follow-up visits with completion
         of questionnaires, blood samples and maternal milk samples are performed at three
         days, and one, three, eight and 12&nbsp;weeks after intervention. (EPDS: Edinburgh Postnatal
         Depression Scale; Hb: haemoglobin; HELLP: haemolysis, elevated liver enzymes, and
         low platelet count; MFI: Multidimensional Fatigue Inventory; PPH: postpartum haemorrhage;
         PPQ: Postpartum Questionnaire; RBC: red blood cells; subMFI: subscale of the Multidimensional
         Fatigue Inventory; subPPQ: subscale of the Postpartum Questionnaire).
      </div></div>
      <h4>Exclusion criteria</h4>
      <p style="line-height:160%">Exclusion criteria: age &lt;18&nbsp;years; multiple births; peripartum RBC transfusion; known
         iron overload or disturbances in the utilisation of iron (such as haemochromatosis
         or haemosiderosis); known hypersensitivity to parenteral iron or any excipients in
         the investigational drug products; a history of active asthma within the previous
         five years; a history of multiple allergies; known decompensated liver cirrhosis or
         active hepatitis; haemolysis, elevated liver enzymes, and low platelet count (HELLP)
         syndrome; active acute infection (clinical symptoms or fever above 38.5°C); rheumatoid
         arthritis; history of anaemia caused by a known haematological disorder other than
         iron deficiency; inability to read, speak and understand the Danish language; participation
         in any other clinical study where the study drug has not passed five half-lives prior
         to the baseline and any other medical condition that, in the opinion of the investigator,
         may cause the parturient to be unsuitable for completion of the study or place her
         at potential risk from participating in the study.
      </p>
      <h4>Randomisation</h4>
      <p style="line-height:160%">Participants will be randomised using an interactive web response system (eClinical
         OS™, Merge Healthcare, Morrisville, NC, United States). The randomisation lists will
         be prepared centrally by the contract research organization BioStata ApS, Birkerød,
         Denmark using a validated computer program. The randomisation will be stratified by
         bleeding volume (PPH: 700 to 1,000&nbsp;mL or PPH &gt;1,000&nbsp;mL). Within each bleeding category,
         there will be a 1:1 randomisation ratio to one of the two treatment groups.
      </p>
      <h4>Intervention</h4>
      <p style="line-height:160%">The participants will be randomised to either standard medical care or iron isomaltoside
         1000. Standard medical care (current treatment practice) at the Department of Obstetrics,
         Copenhagen University Hospital, Rigshospitalet is typically to recommend women with
         PPH to either continue oral iron supplementation, as during pregnancy (the Danish
         Health and Medicines Authority recommends 40 to 50&nbsp;mg oral iron supplementation daily
         <a name="d70682e368"></a>[<a onclick="LoadInParent('#B35'); return false;" href="#B35">35</a>]), or to take 100&nbsp;mg oral iron one or two times daily for a variable time period.
         The actual use of iron supplementation, including specific preparation, dose and duration
         of treatment, will be monitored at each follow-up visit.
      </p>
      <p style="line-height:160%">Immediately after acute bleeding such as PPH, the Hb level is inaccurate for calculating
         individual dosing of iron supplementation. Hence, the iron isomaltoside 1000 fixed
         dosage in this study is based on the expected iron deficiency in women after PPH.
         Body iron stores are approximately 500 to 750&nbsp;mg and the average iron loss through
         PPH is approximately 500&nbsp;mg, as 500&nbsp;mL blood loss equals 250&nbsp;mg iron loss <a name="d70682e374"></a>[<a onclick="LoadInParent('#B4'); return false;" href="#B4">4</a>]. In previous studies of women with postpartum anaemia, oral iron treatment dosages
         were 130 to 200&nbsp;mg per day over a period of 42 to 84&nbsp;days, resulting in a total average
         dose of 11.088&nbsp;mg <a name="d70682e378"></a><a name="d70682e380"></a><a name="d70682e382"></a><a name="d70682e384"></a><a name="d70682e386"></a>[<a onclick="LoadInParent('#B23'); return false;" href="#B23">23</a>-<a onclick="LoadInParent('#B27'); return false;" href="#B27">27</a>]. The intestinal iron absorption varies considerably but is believed to be a maximum
         of 10% <a name="d70682e390"></a>[<a onclick="LoadInParent('#B36'); return false;" href="#B36">36</a>], resulting in a total expected absorption of 1,100 to 1,200&nbsp;mg. Thus, the cumulated
         iron dosages in these studies are in accordance with the chosen treatment dose in
         this study.
      </p>
      <p style="line-height:160%">In the group allocated to iron isomaltoside 1000, Pharmacosmos A/S, Holbaek, Denmark,
         the iron replacement dose is set to 1,200&nbsp;mg. The dose is diluted in 100&nbsp;mL 0.9% sodium
         chloride, Fresenius Kabi AG, Bad Homburg, Germany, and administered over a period
         of approximately 15&nbsp;minutes. No test dose is applied. Participants with a pre-pregnancy
         weight &lt;45&nbsp;kg will receive a reduced single dose of 1,000&nbsp;mg iron isomaltoside 1000,
         administered in the same fashion. In both treatment groups, participants may be given
         a ‘rescue’ allogeneic RBC transfusion if this procedure is clinically indicated.
      </p>
      <h4>Setting, location and follow-up</h4>
      <p style="line-height:160%">The parturients will be screened for inclusion in the study over an 18-month period
         at the Department of Obstetrics, Copenhagen University Hospital, Rigshospitalet, a
         tertiary hospital that performs between 6,000 and 7,000 deliveries per year. Eligible
         parturients are informed about the study and must provide their written consent within
         48&nbsp;hours after delivery. The duration for each individual participant is approximately
         12&nbsp;weeks and involves five follow-up visits by a midwife at the participant’s home.
         The timeframes of the follow-up visits are three days (between two and four days),
         one week (between six and eight days), three weeks (between 19 and 23&nbsp;days), eight
         weeks (between seven and nine weeks) and 12&nbsp;weeks (between 11 and 13&nbsp;weeks).
      </p>
      <h4>Outcomes and safety measures</h4>
      <p style="line-height:160%">The primary outcome is the aggregated change in physical fatigue score within 12&nbsp;weeks
         postpartum, as measured by a subscale of the Multidimensional Fatigue Inventory (MFI)
         <a name="d70682e408"></a>[<a onclick="LoadInParent('#B37'); return false;" href="#B37">37</a>]. Secondary efficacy outcomes include changes in the Hb concentration, <em>p-</em>ferritin, <em>p-</em>iron, <em>p-</em>transferrin, transferrin saturation, reticulocyte count, mean reticulocyte Hb content,
         other MFI and Postpartum Questionnaire (PPQ) fatigue items, symptoms of postpartum
         depression, time of postpartum lactogenesis, time of discontinuation of breastfeeding
         and transfusion of allogeneic RBCs.
      </p>
      <p style="line-height:160%">The safety outcomes are discontinuation due to intolerance, frequency, nature and
         severity of adverse events, vital signs, and <em>p</em>-sodium, <em>p-</em>potassium, <em>p-</em>calcium, <em>p-</em>phosphate, <em>p-</em>urea, <em>p-</em>creatinine, <em>p-</em>albumin, <em>p</em>-bilirubin, <em>p</em>-aspartate aminotransferase and <em>p</em>-alanine aminotransferase levels. Other outcomes are maternal milk iron level, anaemia
         symptoms and gastrointestinal symptoms.
      </p>
      <h4>Questionnaires</h4>
      <p style="line-height:160%">We will use the three following self-reported questionnaires: the fatigue measures
         MFI and PPQ and the depression measure Edinburgh Postnatal Depression Scale (EPDS)
         <a name="d70682e460"></a>[<a onclick="LoadInParent('#B38'); return false;" href="#B38">38</a>]. Of these, the MFI includes the scale of physical fatigue, which is the primary endpoint
         of this investigation.
      </p>
      <p style="line-height:160%">The MFI has been found to have high feasibility, reliability and validity in chronically
         anaemic women <a name="d70682e466"></a>[<a onclick="LoadInParent('#B39'); return false;" href="#B39">39</a>] and in postpartum women <a name="d70682e470"></a>[<a onclick="LoadInParent('#B40'); return false;" href="#B40">40</a>]. The MFI covers the following dimensions: general fatigue, physical fatigue, reduced
         activity, reduced motivation and mental fatigue. The MFI consists of 20 statements
         for which the participant indicates, on a five-point scale, the extent to which the
         particular statement applies to her. The statements refer to aspects of fatigue experienced
         during the previous days. Higher scores indicate a higher degree of fatigue.
      </p>
      <p style="line-height:160%">The PPQ is a novel and yet to be validated instrument that was developed for this
         study to measure fatigue in parturients [see Additional file <a name="d70682e475"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/5/suppl/S1','',630,470); return false;" href="http://www.trialsjournal.com/content/16/1/5/suppl/S1">1</a> (in Danish)]. It consists of a visual analogue scale of how tired the participant
         is and five questions regarding fatigue. The first question concerns what the participant
         experiences as most troublesome, pain or fatigue. The second question concerns whether
         the fatigue is experienced most physically or mentally. For each of the first two
         questions the participant is asked to underline one of five possible responses. The
         last three questions explore how the fatigue influences breastfeeding, contact with
         the newborn and to what extend the participant asks for help with nappy changing.
         The participant is asked to indicate, on a four-point scale, the extent of the influence
         of the fatigue. Higher scores from the last three questions indicate a higher degree
         of fatigue.
      </p><div class="figs">
      <div class="addfile"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/5/suppl/S1','S1',630,470); return false;" href="http://www.trialsjournal.com/content/16/1/5/suppl/S1"></a><strong>Additional file 1.</strong> <strong>Postpartum Questionnaire.</strong></p><p>
         	Format: PDF 
         	Size: 64KB <a href="/content/supplementary/1745-6215-16-5-s1.pdf">Download file</a></p><p>This file can be viewed with: <a onclick="largepopup('http://www.adobe.com/products/acrobat/readstep.html','Help');return false;" href="http://www.adobe.com/products/acrobat/readstep.html">Adobe Acrobat Reader</a><span class="open-data-icon"><a href="/about/access/#opendata"><img title="Open Data" alt="Open Data" src="/bmcimages/article/opendata.gif"></a></span></div></div>
      <p style="line-height:160%">The EPDS is a screening instrument that was developed to detect symptoms of depression
         in puerperal women. A number of studies have confirmed that the EPDS is both reliable
         and sensitive <a name="d70682e492"></a>[<a onclick="LoadInParent('#B41'); return false;" href="#B41">41</a>]. The EPDS consists of 10 questions. Participants are asked to underline one of four
         possible responses that comes closest to how she has been feeling during the previous
         seven days. The maximum score is 30 and a score of 10 or higher indicates possible
         depression.
      </p>
      <h4>Monitoring and data collection</h4>
      <p style="line-height:160%">The data collection tool for this study is an electronic case report form. Data necessary
         for analyses and reporting will be entered into a validated and secured data system.
         Clinical data management is performed in accordance with applicable standards and
         data cleaning procedures.
      </p>
      <p style="line-height:160%">A clinical research associate (CRA) from a contract research organisation will monitor
         the study for protocol compliance, verifying that safety procedures and the rights
         of participants are being protected. The CRA will also verify that the study is conducted
         in accordance with the currently approved protocol and any other study agreements,
         ICH-GCP guidelines and all applicable regulatory requirements. The CRA will also monitor
         and verify that data are authentic, accurate and complete.
      </p>
      <h4>Number of participants</h4>
      <p style="line-height:160%">The following hypothesis will be tested: iron isomaltoside 1000 is superior to standard
         medical care in the treatment of iron deficiency in women with PPH with or without
         anaemia, measured primarily by a reduction in physical fatigue. The null hypothesis
         of no difference between the treatment groups will be tested against the alternative
         by constructing a two-sided 95% confidence interval of the difference in aggregated
         change in physical fatigue score from baseline to week 12 between the two treatment
         groups. The sample size calculations are based on the primary endpoint, aggregated
         change in physical fatigue score from baseline to week 12. A two-sided significance
         level of 5% is used and the power is set to 80%.
      </p>
      <p style="line-height:160%">The use of the physical fatigue subscale of MFI allows a maximum change of 16 points.
         Based on clinical judgement and consensus between all authors, we wish to see a difference
         greater than 10% for claiming clinically relevant superiority. Hence, we set the minimal
         clinically relevant difference to 1.8. In a previous study, the standard deviation
         was found to be approximately 4.2 <a name="d70682e512"></a>[<a onclick="LoadInParent('#B40'); return false;" href="#B40">40</a>]. Therefore, 87 patients per treatment group are needed in order to demonstrate superiority.
         With a margin for missing data and a dropout rate of 13%, 200 women will be included.
      </p>
      <h4>Statistical methods and data analysis</h4>
      <p style="line-height:160%">All tests are pre-specified in a statistical analysis plan. The primary analysis population
         will be the full analysis set, including all randomised participants who received
         the study drug and have at least one post-baseline physical fatigue score. The primary
         endpoint is the aggregated change in the physical fatigue score from baseline to week
         12. This will be calculated as the area under the curve of the changes in the physical
         fatigue score from baseline to each visit until week 12, divided by the number of
         scheduled days (observation period). The area under the curve will be calculated using
         the linear trapezoidal method and scheduled days. The primary endpoint will be analysed
         using an analysis of variance model, with treatment and amount of PPH (700 to 1,000&nbsp;mL
         or &gt;1,000&nbsp;mL) as factors, and baseline MFI physical fatigue score as the covariate.
         The estimated treatment differences (iron isomaltoside 1000 versus standard medical
         care) expressed as contrasts of the adjusted means will be presented with corresponding
         95% confidence intervals and the <em>P</em> value. Iron isomaltoside 1000 will be considered superior to standard medical care
         if the lower limit of the 95% confidence interval is above zero. We will also perform
         a per protocol analysis excluding participants with major protocol deviations, such
         as rescue allogeneic RBC transfusion.
      </p>
      <p style="line-height:160%">All statistical tests of the efficacy endpoints will be two-sided and performed on
         a 5% significance level. Estimated treatment differences and 95% confidence limits
         will be presented together with the corresponding <em>P</em> value. Continuous secondary endpoints will be analysed by a mixed model for repeated
         measurements, including visit and treatment-by-visit, and PPH (700 to 1,000&nbsp;mL or
         &gt;1,000&nbsp;mL) as factors, the baseline value as the covariate, and the subject as the
         random effect. If no baseline value is measured for the endpoint in question, the
         value at the first measured time will be included as the covariate. An unstructured
         covariance structure will be used to model the within-subject errors and the estimation
         method will be a restricted maximum likelihood-based approach. The analysis will be
         based on the ‘missing at random’ assumption and performed using the data from each
         observed case. ‘Proportion’ endpoints will be analysed by logistic regression with
         treatment as the factor. Where relevant, the baseline value of the parameter in question
         will be included as the covariate. Time to postpartum lactogenesis and time to discontinuation
         of breastfeeding will be assessed and analysed using Kaplan-Meier curves and compared
         between treatments using a log-rank test. The laboratory data will be analysed as
         described for the continuous variables above. Adverse events will be summary tabulated
         using the latest version of the Medical Dictionary for Regulatory Activities body
         system and preferred term indicating the number and percentage of participants and
         the number of events. The number of participants who experience an adverse drug reaction,
         including suspected unexpected serious adverse reactions, will be compared between
         treatment groups.
      </p>
      <h4>Consent and ethical considerations</h4>
      <p style="line-height:160%">Women planning to give birth at the Department of Obstetrics, Copenhagen University
         Hospital, Rigshospitalet have received written information about the study at one
         of their antenatal midwife consultations. When a parturient fulfils the inclusion
         criteria, she will be asked to participate in the study after receiving oral and written
         information from an investigator. In obtaining and documenting informed consent, the
         investigator will comply with any applicable regulatory requirements, and will adhere
         to ICH-GCP and the Declaration of Helsinki. The National Committee on Biomedical Research
         Ethics (approval number: H-4-2013-019) and the Danish Medicines Agency (approval number:
         EudraCT 2012-005782-12) have approved the study. The trial is registered at Clinicaltrials.gov
         (identifier: NCT01895218).
      </p>
   </div>
</section>
<section><a name="sec3"></a><h3>Discussion</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">The aim of this study is to compare a new treatment option (iron isomaltoside 1000)
         to standard medical care. The choice of the latter active comparator, ‘the drug of
         first choice’, enables us to use the results of this study for assessing the potential
         additional benefit of iron isomaltoside 1000 in a clinical setting.
      </p>
      <p style="line-height:160%">The standard medical care treatment group does not receive a general specified recommendation
         of oral iron supplementation. We considered that standard treatment, as defined by
         the individualised regimen chosen by the parturient and her midwife, was the proper
         comparator. A pregnant woman usually takes oral iron supplementation from early pregnancy
         and finds a preparation and a dose that is suitable for her. A general fixed regimen
         might cause gastrointestinal side effects in some individuals, and a possible insufficient
         effect in others. Therefore, the fixed regimen would be suboptimal as a comparator
         compared with the standard individualised regimen, which is current practice in the
         Capital Region of Denmark. The actual use of oral iron, including specific preparation,
         dose and duration of treatment, is registered at each follow-up visit.
      </p>
      <p style="line-height:160%">The individualised regimen design implies that we were not able to blind the randomisation
         in this trial. Also, since iron tablets colour the stools, we assessed that a double-blinded
         design would be unfeasible and would not contribute additional scientific merit. Accordingly,
         most previously published randomised controlled trials with iron treatment of women
         after childbirth have not been double-blinded <a name="d70682e547"></a><a name="d70682e549"></a><a name="d70682e551"></a><a name="d70682e553"></a><a name="d70682e555"></a>[<a onclick="LoadInParent('#B23'); return false;" href="#B23">23</a>-<a onclick="LoadInParent('#B27'); return false;" href="#B27">27</a>].
      </p>
      <p style="line-height:160%">The strength of this trial is the fact that it will be conducted at a single centre.
         This means that the standard medical care is less diverse than it might otherwise
         be and we can ensure a full overview of all parturients with PPH ≥700&nbsp;mL in the time
         period of inclusion, which will enable us to collect detailed information about those
         excluded and the reasons why not.
      </p>
      <p style="line-height:160%">The risk of bias by selecting the subjective endpoint physical fatigue in an open-label
         study is an inherent weakness of the study. Fatigue is an important clinical endpoint
         that has consistently been shown to be affected by iron deficiency and iron deficiency
         anaemia. However, fatigue in the postpartum period is highly dependent on various
         attributes, including the mode and outcome of delivery, the duration of labour, medical
         comorbidities, the health of the infant and a host of social and environmental factors.
         Nevertheless, this design was previously used in a randomised controlled study in
         a similar population, where an open-label design and subjective primary endpoint were
         chosen for the most clinically relevant design <a name="d70682e563"></a>[<a onclick="LoadInParent('#B42'); return false;" href="#B42">42</a>].
      </p>
      <p style="line-height:160%">The instrument used for measuring the primary endpoint is the physical fatigue subscale
         of the MFI. We selected this instrument due to its previous validation, including
         the findings of high feasibility and reliability in the postpartum population, specifically
         its use for measuring fatigue in parturients that experienced PPH. However, no validated
         questionnaires have been specifically developed for measuring postpartum fatigue.
         Although some available questionnaires for measuring fatigue have been validated for
         this population, they are all constructed to measure fatigue in other populations,
         often cancer or other chronic ill patients. Therefore, we developed a new questionnaire
         (PPQ) that is designed specifically to measure fatigue among puerperal women. A further
         objective of this study is to assess and validate its ability to measure fatigue in
         women after PPH.
      </p>
   </div>
</section>
<section><a name="sec4"></a><h3>Trial status</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">The trial was initiated and the first parturient was included in May 2013. Inclusion
         and randomisation are ongoing and expected to be finished in August 2014.
      </p>
   </div>
</section>
<section><a name="sec5"></a><h3>Abbreviations</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">CRA: clinical research associate; EPDS: Edinburgh Postnatale Depression Scale; Hb:
         haemoglobin; HELLP: haemolysis, elevated liver enzymes, and low platelet count; ICH-GCP:
         International Conference on Harmonization – Good Clinical Practice; MFI: Multidimensional
         Fatigue Inventory; PPH: postpartum haemorrhage; PPQ: Postpartum questionnaire; RBC:
         red blood cells.
      </p>
   </div>
</section>
<section><a name="sec6"></a><h3>Competing interests</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">CH is an industrial PhD student and LLT is employed by Pharmacosmos A/S. JLR is the
         primary investigator employed by the Department of Obstetrics, Copenhagen University
         Hospital, Rigshospitalet, and AN is the primary investigator of an ongoing Pharmacosmos
         A/S-sponsored clinical trial. The institution receives a fee per patient.
      </p>
   </div>
</section>
<section><a name="sec7"></a><h3>Authors’ contributions</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">CH, JLR, LLT and AN were involved in the conception and design of the study. All authors
         were involved in drafting the protocol and revising it critically. All authors have
         approved the final manuscript.
      </p>
   </div>
</section>
<section><a name="ack"></a><h3>Acknowledgements</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">The study is sponsored and fully funded by Pharmacosmos A/S. The authors are grateful
         to Jens K Slott Jensen MSc who provided statistical support. The sponsor paid for
         this assistance.
      </p>
   </div>
</section>
<section><a name="refs"></a><h3>References</h3>
   <div id="article-references" class="collapsible-content">
      <ol id="references">
         <li id="B1">
            <p><a name="B1"></a> Gyte G: <strong> The Significance of blood loss at delivery. </strong><p><em>MIDIRS Midwifery Digest</em> 1992,  <strong>2</strong><strong>:</strong>88-92.  <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B1" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B1','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B2">
            <p><a name="B2"></a> Ripley DL: <strong> Uterine emergencies. Atony, inversion, and rupture. </strong><p><em>Obstet Gynecol Clin N Am</em> 1999,  <strong>26</strong><strong>:</strong>419-34.   <a target="_blank" href="http://dx.doi.org/10.1016/S0889-8545(05)70087-5">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B2" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B2','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B3">
            <p><a name="B3"></a>WHO: <em>WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage</em>.  Geneva: World Health Organization Press;  2012. <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B3" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B3','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B4">
            <p><a name="B4"></a> Koury MJ,  Ponka P: <strong> New insights into erythropoiesis: the roles of folate, vitamin B, and iron*. </strong><p><em>Annu Rev Nutr</em> 2004,  <strong>24</strong><strong>:</strong>105-31.  <a target="_blank" href="/pubmed/15189115">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=15189115">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B4" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B4','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B5">
            <p><a name="B5"></a> Lee KA,  Zaffke ME: <strong> Longitudinal changes in fatigue and energy during pregnancy and the postpartum period. </strong><p><em>J Obstetric Gynecol Neonatal Nursing</em> 1999,  <strong>28</strong><strong>:</strong>183-91.   <a target="_blank" href="http://dx.doi.org/10.1111/j.1552-6909.1999.tb01983.x">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B5" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B5','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B6">
            <p><a name="B6"></a> Dewey KG,  Nommsen-Rivers LA,  Heinig MJ,  Cohen RJ: <strong> Risk factors for suboptimal infant breastfeeding behavior, delayed onset of lactation,
                  and excess neonatal weight loss. </strong><p><em>Pediatrics</em> 2003,  <strong>112</strong><strong>:</strong>607-19.  <a target="_blank" href="/pubmed/12949292">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=12949292">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B6" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B6','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B7">
            <p><a name="B7"></a> Chapman DJ,  Pérez-Escamilla R: <strong> Does delayed perception of the onset of lactation shorten breastfeeding duration? </strong><p><em>J Hum Lact</em> 1999,  <strong>15</strong><strong>:</strong>107-11.  <a target="_blank" href="/pubmed/10578785">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=10578785">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B7" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B7','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B8">
            <p><a name="B8"></a> Rioux FM,  Savoie N,  Allard J: <strong> Is there a link between postpartum anemia and discontinuation of breastfeeding? </strong><p><em>Can J Diet Pract Res</em> 2006,  <strong>67</strong><strong>:</strong>72-6.  <a target="_blank" href="/pubmed/16759433">PubMed&nbsp;Abstract</a> |  <a target="_blank" href="http://dx.doi.org/10.3148/67.2.2006.72">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B8" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B8','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B9">
            <p><a name="B9"></a> Bodnar LM,  Cogswell ME,  McDonald T: <strong> Have we forgotten the significance of postpartum iron deficiency? </strong><p><em>Am J Obstet Gynecol</em> 2005,  <strong>193</strong><strong>:</strong>36-44.  <a target="_blank" href="/pubmed/16021056">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=16021056">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B9" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B9','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B10">
            <p><a name="B10"></a> Geisser P,  Baer M,  Schaub E: <strong> Structure/histotoxicity relationship of parenteral iron preparations. </strong><p><em>Arzneimittelforschung</em> 1992,  <strong>42</strong><strong>:</strong>1439-52.  <a target="_blank" href="/pubmed/1288508">PubMed&nbsp;Abstract</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B10" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B10','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B11">
            <p><a name="B11"></a> Lyseng-Williamson KA,  Keating GM: <strong> Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. </strong><p><em>Drugs</em> 2009,  <strong>69</strong><strong>:</strong>739-56.  <a target="_blank" href="/pubmed/19405553">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=19405553">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B11" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B11','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B12">
            <p><a name="B12"></a>European Medicines Agency: <em>Assessments Report for: Iron Containing Intravenous (IV) Medicinal Products</em>.  London: European Medicines Agency;  2013. <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B12" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B12','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B13">
            <p><a name="B13"></a> Jahn MR,  Andreasen HB,  Fütterer S,  Nawroth T,  Schünemann V,  Kolb U, <em>et al</em>.: <strong> A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer),
                  a new intravenous iron preparation and its clinical implications. </strong><p><em>Eur J Pharm Biopharm</em> 2011,  <strong>78</strong><strong>:</strong>480-91.  <a target="_blank" href="/pubmed/21439379">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21439379">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B13" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B13','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B14">
            <p><a name="B14"></a> Hildebrandt PR,  Bruun NE,  Nielsen OW,  Pantev E,  Shiva F,  Videbæk L, <em>et al</em>.: <strong> Effects of administration of iron isomaltoside 1000 in patients with chronic heart
                  failure. A pilot study. </strong><p><em>Transfusion Altern Transfusion Med</em> 2010,  <strong>11</strong><strong>:</strong>131-7.   <a target="_blank" href="http://dx.doi.org/10.1111/j.1778-428X.2010.01145.x">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B14" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B14','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B15">
            <p><a name="B15"></a> Wikström B,  Bhandari S,  Barany P,  Kalra PA,  Ladefoged S,  Wilske J, <em>et al</em>.: <strong> Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic
                  kidney disease. </strong><p><em>J Nephrol</em> 2011,  <strong>24</strong><strong>:</strong>589-96.  <a target="_blank" href="/pubmed/21240875">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21240875">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B15" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B15','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B16">
            <p><a name="B16"></a> Nordfjeld K,  Andreasen H,  Thomsen LL: <strong> Pharmacokinetics of iron isomaltoside 1000 in patients with inflammatory bowel disease. </strong><p><em>Drug Design Dev Therapy</em> 2012,  <strong>6</strong><strong>:</strong>43-51.  <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B16" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B16','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B17">
            <p><a name="B17"></a> Reinisch W,  Staun M,  Tandon RK,  Altorjay I,  Thillainayagam AV,  Gratzer C, <em>et al</em>.: <strong> A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000
                  (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED). </strong><p><em>Am J Gastroenterol</em> 2013,  <strong>108</strong><strong>:</strong>1877-88.  <a target="_blank" href="/pubmed/24145678">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=24145678">Publisher&nbsp;Full&nbsp;Text</a> | <a target="_blank" href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=24145678">PubMed&nbsp;Central&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B17" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B17','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B18">
            <p><a name="B18"></a> Pavord S,  Myers B,  Robinson S,  Allard S,  Strong J,  Oppenheimer C: <strong> UK guidelines on the management of iron deficiency in pregnancy. </strong><p><em>Br J Haematol</em> 2012,  <strong>156</strong><strong>:</strong>588-600.  <a target="_blank" href="/pubmed/22512001">PubMed&nbsp;Abstract</a> |  <a target="_blank" href="http://dx.doi.org/10.1111/j.1365-2141.2011.09012.x">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B18" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B18','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B19">
            <p><a name="B19"></a> Breymann C,  Bian X,  Blanco-Capito LR,  Chong C,  Mahmud G,  Rehman R: <strong> Expert recommendations for the diagnosis and treatment of iron-deficiency anemia during
                  pregnancy and the postpartum period in the Asia-Pacific region. </strong><p><em>J Perinat Med</em> 2011,  <strong>39</strong><strong>:</strong>113-21.  <a target="_blank" href="/pubmed/21070128">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21070128">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B19" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B19','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B20">
            <p><a name="B20"></a> Breymann C,  Hovegger C,  Holzgreve W,  Surbek D: <strong> Diagnosis and treatment of iron-deficiency anaemia during pregnancy and postpartum. </strong><p><em>Arch Gynecol Obstet</em> 2010,  <strong>282</strong><strong>:</strong>577-80.  <a target="_blank" href="/pubmed/20577752">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=20577752">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B20" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B20','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B21">
            <p><a name="B21"></a> Kiss H,  Konnaris C: <strong> Eisenmangelanämie in der Schwangerschaft und postpartum. </strong><p><em>Österreichische Gesellschaft Gynäkologie Geburtshilfe</em> 2011.
               <p>[in German] [<a href="http://www.oeggg.at/fileadmin/user_upload/downloads/Leitlinien/2011_16_03_11_LL_Anaemie_Schwangerschaft_final_1011.pdf">http://www.oeggg.at/fileadmin/user_upload/downloads/Leitlinien/2011_16_03_11_LL_Anaemie_Schwangerschaft_final_1011.pdf</a> <a href="http://www.webcitation.org/query.php?url=http://www.oeggg.at/fileadmin/user_upload/downloads/Leitlinien/2011_16_03_11_LL_Anaemie_Schwangerschaft_final_1011.pdf&amp;refdoi=10.1186/1745-6215-16-5" alt="" title="Archive copy of webpage" class="xpushbutton">webcite</a>]
               </p> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B21" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B21','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B22">
            <p><a name="B22"></a> Merino SG,  Picado AL,  Hernández HM,  Mesa JM,  Lasa IL,  Barandiarán FA: <strong> Ensayo clínico aleatorizado para evaluar la efectividad de dos vías de administración
                  de hierro, oral e intravenosa, en el tratamiento de la anemia ferropénica posparto. </strong><p><em>Clínica Investigación Ginecol Obstetricia</em> 2012,  <strong>39</strong><strong>:</strong>190-5. 
               <p>[in Spanish]</p> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B22" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B22','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B23">
            <p><a name="B23"></a> Westad S,  Backe B,  Salvesen KÅ,  Nakling J,  Økland I,  Borthen I, <em>et al</em>.: <strong> A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous
                  sulphate for treatment of postpartum anemia. </strong><p><em>Acta Obstet Gynecol Scand</em> 2008,  <strong>87</strong><strong>:</strong>916-23.  <a target="_blank" href="/pubmed/18720044">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=18720044">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B23" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B23','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B24">
            <p><a name="B24"></a> Bhandal N,  Russell R: <strong> Intravenous versus oral iron therapy for postpartum anaemia. </strong><p><em>BJOG Int J Obstetrics Gynaecol</em> 2006,  <strong>113</strong><strong>:</strong>1248-52.   <a target="_blank" href="http://dx.doi.org/10.1111/j.1471-0528.2006.01062.x">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B24" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B24','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B25">
            <p><a name="B25"></a> van Wyck DB,  Martens MG,  Seid MH,  Baker JB,  Mangione A: <strong> Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum
                  anemia: a randomized controlled trial. </strong><p><em>Obstet Gynecol</em> 2007,  <strong>110</strong><strong>:</strong>267-78.  <a target="_blank" href="/pubmed/17666600">PubMed&nbsp;Abstract</a> |  <a target="_blank" href="http://dx.doi.org/10.1097/01.AOG.0000275286.03283.18">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B25" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B25','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B26">
            <p><a name="B26"></a> Seid MH,  Derman RJ,  Baker JB,  Banach W,  Goldberg C,  Rogers R: <strong> Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia:
                  a randomized controlled clinical trial. </strong><p><em>Am J Obstet Gynecol</em> 2008,  <strong>199</strong><strong>:</strong>435. 
               <p>e1–7</p> <a target="_blank" href="/pubmed/18928998">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=18928998">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B26" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B26','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B27">
            <p><a name="B27"></a> Breymann C,  Gliga F,  Bejenariu C,  Strizhova N: <strong> Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment
                  of postpartum iron deficiency anemia. </strong><p><em>Int J Gynecol Obstet</em> 2008,  <strong>101</strong><strong>:</strong>67-73.   <a target="_blank" href="http://dx.doi.org/10.1016/j.ijgo.2007.10.009">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B27" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B27','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B28">
            <p><a name="B28"></a> Verma S,  Inamdar S,  Malhotra N: <strong> Intravenous iron therapy versus oral iron in postpartum patients in rural area. </strong><p><em>J South Asian Federation Obstetrics Gynaecol</em> 2011,  <strong>3</strong><strong>:</strong>67-70.  <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B28" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B28','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B29">
            <p><a name="B29"></a> Froessler B,  Cocchiaro C,  Saadat-Gilani K,  Hodyl N,  Dekker G: <strong> Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum
                  iron deficiency anemia: a randomized trial. </strong><p><em>J Matern Fetal Neonatal Med</em> 2013,  <strong>26</strong><strong>:</strong>654-9.  <a target="_blank" href="/pubmed/23130909">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=23130909">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B29" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B29','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B30">
            <p><a name="B30"></a> Jain G,  Palaria U,  Jha SK: <strong> Intravenous iron in postpartum anemia. </strong><p><em>J Obstetrics Gynecol India</em> 2013,  <strong>63</strong><strong>:</strong>45-8.   <a target="_blank" href="http://dx.doi.org/10.1007/s13224-012-0240-y">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B30" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B30','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B31">
            <p><a name="B31"></a> Mumtaz A,  Farooq F: <strong> Comparison for Effects of Intravenous versus Oral Iron Therapy for Postpartum Anemia. </strong><p> 2014.
               <p>[<a href="http://pjmhsonline.com/comparison_for_effects_of_intrav.htm">http://pjmhsonline.com/comparison_for_effects_of_intrav.htm</a> <a href="http://www.webcitation.org/query.php?url=http://pjmhsonline.com/comparison_for_effects_of_intrav.htm&amp;refdoi=10.1186/1745-6215-16-5" alt="" title="Archive copy of webpage" class="xpushbutton">webcite</a>]
               </p></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B32">
            <p><a name="B32"></a> Milman N: <strong> Postpartum anemia I: definition, prevalence, causes, and consequences. </strong><p><em>Ann Hematol</em> 2011,  <strong>90</strong><strong>:</strong>1247-53.  <a target="_blank" href="/pubmed/21710167">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21710167">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B32" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B32','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B33">
            <p><a name="B33"></a> Dodd JM,  Dare MR,  Middleton P: <strong> Treatment for women with postpartum iron deficiency anaemia. </strong><p><em>Cochrane Database Syst Rev</em> 2004, CD004222.  <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B33" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B33','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B34">
            <p><a name="B34"></a>International Conference on Harmonisation of Technical Requirements for Registration
               of Pharmaceuticals for Human Use: <em>ICH Harmonised Tripartite Guideline - Guideline for Good Clinical Practice E6 (R1)</em>.  London: European Medicines Agency;  2002. <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B34" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B34','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B35">
            <p><a name="B35"></a><strong> National Board of Health: Healthy Habits – Before, During and After Pregnancy </strong><p> 2010.
               <p>[<a href="http://sundhedsstyrelsen.dk/publ/Publ2010/CFF/English/SundeVaner_en.pdf">http://sundhedsstyrelsen.dk/publ/Publ2010/CFF/English/SundeVaner_en.pdf</a> <a href="http://www.webcitation.org/query.php?url=http://sundhedsstyrelsen.dk/publ/Publ2010/CFF/English/SundeVaner_en.pdf&amp;refdoi=10.1186/1745-6215-16-5" alt="" title="Archive copy of webpage" class="xpushbutton">webcite</a>]
               </p></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B36">
            <p><a name="B36"></a> Crichton RR,  Wilmet S,  Legssyer R,  Ward RJ: <strong> Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. </strong><p><em>J Inorg Biochem</em> 2002,  <strong>91</strong><strong>:</strong>9-18.  <a target="_blank" href="/pubmed/12121757">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=12121757">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B36" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B36','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B37">
            <p><a name="B37"></a> Smets EM,  Garssen B,  Bonke B,  de Haes JC: <strong> The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument
                  to assess fatigue. </strong><p><em>J Psychosom Res</em> 1995,  <strong>39</strong><strong>:</strong>315-25.  <a target="_blank" href="/pubmed/7636775">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=7636775">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B37" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B37','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B38">
            <p><a name="B38"></a> Cox JL,  Holden JM,  Sagovsky R: <strong> Detection of postnatal depression. Development of the 10-item Edinburgh postnatal
                  depression scale. </strong><p><em>Br J Psychiatry</em> 1987,  <strong>150</strong><strong>:</strong>782-6.  <a target="_blank" href="/pubmed/3651732">PubMed&nbsp;Abstract</a> |  <a target="_blank" href="http://dx.doi.org/10.1192/bjp.150.6.782">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B38" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B38','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B39">
            <p><a name="B39"></a> Jansen AJG,  Essink-Bot M,  Beckers EAM,  Hop WCJ,  Schipperus MR,  van Rhenen DJ: <strong> Quality of life measurement in patients with transfusion-dependent myelodysplastic
                  syndromes. </strong><p><em>Br J Haematol</em> 2003,  <strong>121</strong><strong>:</strong>270-4.  <a target="_blank" href="/pubmed/12694248">PubMed&nbsp;Abstract</a> |  <a target="_blank" href="http://dx.doi.org/10.1046/j.1365-2141.2003.04272.x">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B39" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B39','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B40">
            <p><a name="B40"></a> Jansen AJG,  Essink-Bot M,  Duvekot JJ,  van Rhenen DJ: <strong> Psychometric evaluation of health-related quality of life measures in women after
                  different types of delivery. </strong><p><em>J Psychosom Res</em> 2007,  <strong>63</strong><strong>:</strong>275-81.  <a target="_blank" href="/pubmed/17719365">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=17719365">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B40" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B40','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B41">
            <p><a name="B41"></a> Gibson J,  McKenzie-McHarg K,  Shakespeare J,  Price J,  Gray R: <strong> A systematic review of studies validating the Edinburgh postnatal depression scale
                  in antepartum and postpartum women. </strong><p><em>Acta Psychiatr Scand</em> 2009,  <strong>119</strong><strong>:</strong>350-64.  <a target="_blank" href="/pubmed/19298573">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=19298573">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B41" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B41','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B42">
            <p><a name="B42"></a> Prick BW,  Steegers EA,  Jansen AG,  Hop WC,  Essink-Bot M,  Peters NC, <em>et al</em>.: <strong> Well being of obstetric patients on minimal blood transfusions (WOMB trial). </strong><p><em>BMC Pregnancy Childbirth</em> 2010,  <strong>10</strong><strong>:</strong>83.  <a target="_blank" href="/pubmed/21162725">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://dx.doi.org/10.1186/1471-2393-10-83">BioMed&nbsp;Central&nbsp;Full&nbsp;Text</a> | <a target="_blank" href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=21162725">PubMed&nbsp;Central&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=1745-6215-16-5&amp;bibl=B42" onclick="popup('/sfx_links?ui=1745-6215-16-5&amp;bibl=B42','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
      </ol>
   </div>
</section>
    <br class="clearall">
<div class="article-alert-signup-div">

<a class="close png_bg" id="closeHelpBox" >close</a>	
<div class="article-alert-signup rounded" > 
<span class="blurb left">Sign up to receive new article alerts from <em>Trials</em></span>

	
				<button name="articleAlertPreference.status" type="button" class="w74 right" onClick="window.location='/my/preferences'">Sign up</button>
	
</div>
</div></div>
    </div></div>
</div>


		</div>
</div>

    <hr class="hide" />
	
    

						
   
  
      
  
                  
  
                  
  
            
  
            
            


<div id="footer">

						
			<span class="views"><a id="mobile-view" href="?fmt_view=mobile">Mobile view</a> | <strong>Desktop view</strong></span>
			
	<div class="content">
    <div class="rounded ">
<div class="wrap-inner ">
        	
    <ul class="desktop">
                                                    
				        <li class="noborder"><a href="http://www.biomedcentral.com/about/tandc">Terms and Conditions</a></li>
<li><a href="http://www.biomedcentral.com/about/privacy">Privacy statement</a></li>
<li><a href="http://www.biomedcentral.com/presscenter">Press</a></li>
	<li><a href="http://www.biomedcentral.com/advertisers">Information for advertisers</a></li>
<li><a href="http://www.biomedcentral.com/about/bmcjobs">Jobs at BMC</a></li>
<li><a href="/support">Support</a></li>
<li><a href="/about/contact">Contact us</a></li>


    
    	    </ul>
    <p id="copyright">&copy; 2015 
	BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business&nbsp;Media.</p>
        </div>
</div>

	</div>

</div>
<div class="springer">
    <a href="http://www.springer.com/" target="blank"><img style="float:right; margin:0;" src="
    //www.biomedcentral.com/images/Springer_Branding_footer_logo.png" /></a>
</div>


<script>window.bmcIsMobile = "classic";</script>					    

<script>
// getElementsByClassName Polyfill
var getElementsByClassName=function(e,t,n){if(document.getElementsByClassName){getElementsByClassName=function(e,t,n){n=n||document;var r=n.getElementsByClassName(e),i=t?new RegExp("\\b"+t+"\\b","i"):null,s=[],o;for(var u=0,a=r.length;u<a;u+=1){o=r[u];if(!i||i.test(o.nodeName)){s.push(o)}}return s}}else if(document.evaluate){getElementsByClassName=function(e,t,n){t=t||"*";n=n||document;var r=e.split(" "),i="",s="http://www.w3.org/1999/xhtml",o=document.documentElement.namespaceURI===s?s:null,u=[],a,f;for(var l=0,c=r.length;l<c;l+=1){i+="[contains(concat(' ', @class, ' '), ' "+r[l]+" ')]"}try{a=document.evaluate(".//"+t+i,n,o,0,null)}catch(h){a=document.evaluate(".//"+t+i,n,null,0,null)}while(f=a.iterateNext()){u.push(f)}return u}}else{getElementsByClassName=function(e,t,n){t=t||"*";n=n||document;var r=e.split(" "),i=[],s=t==="*"&&n.all?n.all:n.getElementsByTagName(t),o,u=[],a;for(var f=0,l=r.length;f<l;f+=1){i.push(new RegExp("(^|\\s)"+r[f]+"(\\s|$)"))}for(var c=0,h=s.length;c<h;c+=1){o=s[c];a=false;for(var p=0,d=i.length;p<d;p+=1){a=i[p].test(o.className);if(!a){break}}if(a){u.push(o)}}return u}}return getElementsByClassName(e,t,n)}
</script>

						



<script type="text/javascript">
if (typeof jQuery == 'undefined') { document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.min.js' type='text/javascript'%3E%3C/script%3E")); }


document.documentElement.id = "js";

var site = {
			abbreviation: "",
	        type: "BMC_NICHE",
        portalId: "9001",
                section: "browse",
                page: "fulltext",
    		
									homePortal: "biomedcentral.com",
		
			siteShowAds: "true",
				showAds: "true",
				url: "trialsjournal.com",
			portal: false,
	        adpage_url: "trialsjournal.com/article/10.1186/1745/6215/16/5",
        id: "10096",
	name: "Trials",
	plugins: {
		scrollable: (getElementsByClassName("scrollable").length > 0),
				flowplayer: ((document.getElementById("flowplayer") != null) || (getElementsByClassName("myPlayer").length > 0) || (document.getElementById("videoarticle") != null) || (getElementsByClassName("flowplayer").length > 0) || (document.getElementById("audio") != null) || (document.getElementById("elifeplayer") != null)),
		lightbox: ((document.getElementById("image-highlight") != null) || (getElementsByClassName("lightbox").length > 0)),
		thickbox: (getElementsByClassName("thickbox").length > 0),
		altmetric: ((document.getElementById("altmetric") != null) || (getElementsByClassName("altmetric").length > 0))
	}
	
};



if(typeof quoteSearchUri == "undefined") { quoteSearchUri=null; }
</script>



        <script type="text/javascript" src="http://www.bmcimg.com/javascript/journals/behaviours-0.js"></script>






		<script>
	if (site.plugins.scrollable == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.scrollable-1.0.1.min.js' %3E%3C/script%3E")); 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.tools.min.js'%3E%3C/script%3E"));
	}

	if (site.plugins.flowplayer == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/flowplayer-3.2.6.min.js'%3E%3C/script%3E"));
	}

	if (site.plugins.lightbox == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/browse_imagehighlight.js'%3E%3C/script%3E"));
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.colorbox.js' %3E%3C/script%3E"));
	}

	if (site.plugins.thickbox == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/thickbox-compressed.js' %3E%3C/script%3E"));
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/thickbox-flashhidden-patch.js' %3E%3C/script%3E"));
	}
	</script>





            <script type="text/javascript" src="http://www.bmcimg.com/javascript/plugins/jquery.fancybox-1.3.1.pack-0.js"></script>
            <script type="text/javascript" src="http://www.bmcimg.com/javascript/plugins/jquery.debug-0.js"></script>
                      <script type="text/javascript" src="http://www.bmcimg.com/javascript/email_preferences/email_preferences-0.js"></script>
                <script type="text/javascript" src="http://www.bmcimg.com/javascript/articles/articles-0.js"></script>
		<div id="fb-root"></div>











        <script type="text/javascript" src="/javascript/plugins/jquery.tagcloud.min-0.js"></script>




<!--[if lte IE 6]>
            <script type="text/javascript" src="/javascript/plugins/DD_belatedPNG_0.0.8a-0.js"></script>
    <script type="text/javascript">
        DD_belatedPNG.fix('.png_bg, ul.primary-nav li a, ul.primary-nav li a span, ul.secondary-nav li a, ul.secondary-nav li a span, ul li i, .plus-button, .facebook, .twitter, .fancy-bg, #fancybox-close');
    </script>
	                <link rel="stylesheet" type="text/css" href="http://www.bmcimg.com/css/hacks/ie6-0.css"/>
    <![endif]-->

<!-- Claudia Whitcombe wanted this comment here -->

       <div class="hide">
      <dl class="google-ad" id="x96banner">
        <dt style="display: block;" class="hide">
          <a class="skyscraper-ad" href="http://www.biomedcentral.com/advertisers/digital_advertising">Advertisement</a>
       </dt>
        <dd>
          <!-- OAS AD 'x96' begin -->
          <script type="text/javascript">
            OAS_AD('x96');
          </script>
        </dd>
      </dl>
    </div>  
    
</body>
</html>

